Healthcare platform CureBay has acquired the pharmacy distribution business of Saveo Healthtech, thereby strengthening medicine supply chains across semi-urban and underserved regions. This strategic move significantly enhances CureBay’s ability to streamline last-mile drug delivery while expanding its operational footprint.
Through this acquisition, CureBay integrates a well-established distribution network that caters to more than 10,000 retail pharmacies across southern India. In addition, the deal includes key infrastructure such as distribution hubs in Bengaluru and Hyderabad, advanced procurement systems, and a technology-driven ordering platform. However, the companies have not disclosed the financial details of the transaction.
Notably, this development reflects a broader industry trend where healthcare startups are increasingly focusing on controlling critical components of the value chain. In particular, drug distribution remains a key challenge, as fragmented logistics and frequent stock-outs continue to disrupt patient care, especially outside metro cities. Therefore, this acquisition positions CureBay to address these inefficiencies more effectively.
CureBay, which currently operates over 190 eClinics across 15,000 villages, claims to have served more than one million patients. Furthermore, the company stated that integrating Saveo’s capabilities will enhance inventory visibility, minimize supply gaps, and accelerate fulfilment cycles—especially for chronic therapies and essential medicines.
“Medicines are central to continuity of care,” said Founder and Chief Executive Priyadarshi Mohapatra, adding that the deal would strengthen procurement and enable faster expansion into new geographies.
Moreover, the combined platform is expected to improve demand planning and optimize working capital management—two areas that have historically limited pharmacy access in rural markets. Meanwhile, CureBay continues to scale its clustered expansion strategy, with two clusters reportedly achieving operating profitability in eastern India.
For Saveo, on the other hand, the transaction signals a strategic shift from operating an independent distribution network to becoming part of a broader, integrated healthcare ecosystem. While its existing pharmacy partners will remain within the system, CureBay’s clinics will benefit from a stronger and more reliable backend supply chain. As part of this transition, Saveo Co-founder Amit Kumar will lead pharmacy technology at CureBay, while senior executive Deepak Tiwary will oversee operations. Consequently, this leadership integration will ensure continuity and improve operational efficiency post-acquisition.
At a broader level, this move highlights increasing consolidation within India’s fragmented pharmaceutical supply ecosystem. Startups are now blending digital tools with physical distribution networks to improve accessibility in smaller towns and rural areas, thereby bridging longstanding healthcare gaps.
Backed by prominent investors such as Bertelsmann India Investments, Elevar Equity, and British International Investment, CureBay is steadily positioning itself as a fully integrated healthcare provider. By combining consultations, diagnostics, and pharmacy services, the company aims to serve populations that remain underserved by traditional healthcare infrastructure.
CureBay’s acquisition of Saveo Healthtech’s pharmacy distribution business marks a decisive step toward building a more resilient and efficient healthcare supply chain in India. As the company deepens its reach into semi-urban and rural markets, it is likely to play a pivotal role in improving access to essential medicines and ensuring continuity of care at scale.
